GO
Loading...

Gilead Sciences Inc

More

  • Most active Nasdaq-traded stocks Wednesday, 24 Dec 2014 | 6:02 PM ET

    Achillion Pharmaceuticals Inc. rose 10.3 percent to $13.06 with 12,986,900 shares traded. American Realty Capital Properties Inc. was unchanged at $8.33 with 18,528,800 shares traded. Apple Inc. fell. 5 percent to $112.01 with 14,146,700 shares traded.

  • *Initial jobless claims fall for fourth straight week. *Biotech shares rebound after sharp two-day decline; energy falls. NEW YORK, Dec 24- U.S. stocks closed flat in a short session on Wednesday as investors found few reasons to push major indexes to their sixth straight day of gains despite strength in biotechs and bullish labor market data.

  • *Initial jobless claims fall for fourth straight week. *Equity markets close at 1 p.m. in holiday-shortened session. NEW YORK, Dec 24- U.S. stocks edged higher on Wednesday, with the Dow and S&P 500 at records and on track for a sixth straight daily advance as biotech stocks rallied and data pointed to improving economic conditions.

  • Early Glance: Biotechnology companies Wednesday, 24 Dec 2014 | 10:23 AM ET

    Amgen Inc. rose $4.40 or 2.8 percent, to $161.92. Biogen Idec rose $4.11 or 1.2 percent, to $339.87. Celgene Corp. rose $3.71 or 3.5 percent, to $109.83.

  • Final Glance: Biotechnology companies Tuesday, 23 Dec 2014 | 6:06 PM ET

    Amgen Inc. fell $7.01 or 4.3 percent, to $157.52. Biogen Idec fell $16.53 or 4.7 percent, to $335.76. Celgene Corp. fell $7.38 or 6.5 percent, to $106.12.

  • Midday Glance: Biotechnology companies Tuesday, 23 Dec 2014 | 1:22 PM ET

    Amgen Inc. fell $9.68 or 5.9 percent, to $154.85. Biogen Idec fell $23.27 or 6.6 percent, to $329.02. Celgene Corp. fell $9.05 or 8.0 percent, to $104.46.

  • Most active Nasdaq-traded stocks Tuesday, 23 Dec 2014 | 1:22 PM ET

    Achillion Pharmaceuticals Inc. fell 23.6 percent to $11.84 with 28,871,400 shares traded. Apple Inc. fell. 4 percent to $112.54 with 24,723,500 shares traded. Celgene Corp. fell 6.5 percent to $106.12 with 17,637,300 shares traded.

  • LOS ANGELES, Dec 23- Express Scripts, the largest manager of prescription drug plans for U.S. employers, is taking an increasingly aggressive stance in price negotiations with pharmaceutical companies after winning discounts on medications with a strategy introduced last year. On Monday, Express Scripts said it lined up a cheaper price for AbbVie Inc's newly...

  • NEW YORK, Dec 23- U.S. stocks advanced on Tuesday, as the Dow climbed above the 18,000 mark for the first time in history and the S&P 500 set a new intraday record after an unexpectedly strong report on economic growth. The gains pushed the Dow as high as 18,051.14, and the index is now up about 175 percent from a 12- year low hit on March 9, 2009. "What was most interesting...

  • NEW YORK, Dec 23- U.S. stock index futures were little changed on Tuesday, after the Dow and S&P 500 closed at fresh records and ahead of a raft of economic data. *Major Wall Street indexes have risen for four straight sessions, pushing the benchmark S&P index to its 50th record high of the year. The S&P has risen 5.4 percent over that period, its best 4- day run since July...

  • Asian shares up after Dow surpasses 18,000 points Tuesday, 23 Dec 2014 | 4:31 AM ET

    In a year full of market milestones, Wall Street crushed a couple more Tuesday, lifting the Dow Jones industrial average past the 18,000- point mark for the first time and delivering the Standard& Poor's 500 index its second record-high close in two days. Investors welcomed the latest encouraging news on the economy as the government said the U.S. grew at the...

  • LOS ANGELES, Dec 23- Express Scripts, the largest manager of prescription drug plans for U.S. employers, is taking an increasingly aggressive stance in price negotiations with pharmaceutical companies after winning discounts on medications with a strategy introduced last year. On Monday, Express Scripts said it lined up a cheaper price for AbbVie Inc's newly...

  • Final Glance: Biotechnology companies Monday, 22 Dec 2014 | 7:19 PM ET

    Amgen Inc. fell $5.64 or 3.3 percent, to $164.53. Biogen Idec fell $8.38 or 2.3 percent, to $352.29. Celgene Corp. fell $3.68 or 3.1 percent, to $113.50.

  • Cramer Remix: This sector is on fire Monday, 22 Dec 2014 | 7:05 PM ET
    Jim Cramer on Mad Money.

    It’s alive! "Mad Money" host Jim Cramer has the way to play an industry that’s buzzing again.

  • Your first trade for Tuesday Monday, 22 Dec 2014 | 6:28 PM ET

    The "Fast Money" traders give their final trades of the day.

  • Cramer: Competition + stocks = Cold-blooded killer Monday, 22 Dec 2014 | 6:11 PM ET
    Facebook headquarters

    Price competition might be a good thing for the consumer, but Jim Cramer recommends running far from the stocks—especially in this sector.

  • Ocwen and Gilead are big market movers Monday, 22 Dec 2014 | 5:30 PM ET

    NEW YORK— Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:. Ocwen Financial Corp., down $5.89 to $16.01. Nabors Industries Ltd., down 53 cents to $13.10.

  • NEW YORK, Dec 22- Equity markets worldwide edged higher on Monday after rising expectations for more European stimulus supported shares in the region, while year-end buying underpinned U.S. stocks. Anticipation of outright government bond buying from the European Central Bank and greater political stability in Greece boosted European bourses.

  • Dec 22- The largest U.S. pharmacy benefit manager said on Monday it has lined up a cheaper price for AbbVie Inc's newly approved hepatitis C treatment and, in most cases, will no longer cover Gilead Sciences Inc's treatments after trying for nearly a year to win a deeper discount. Express Scripts' move reignited investor concerns that pharmaceutical companies...

  • Nasdaq stocks posting largest percentage decreases Monday, 22 Dec 2014 | 1:22 PM ET

    Altisource Portfolio Solutions SA fell 31.3 percent to $32.65. Corium Intl Inc. fell 16.4 percent to $6.56. Rex Energy Corp. fell 13.4 percent to $5.60.